145 related articles for article (PubMed ID: 36076599)
1. Aberrant peribiliary gland niche exacerbates fibrosis in primary sclerosing cholangitis and a potential therapeutic strategy.
Wu S; Cao Y; Lu H; Qi X; Sun J; Ye Y; Gong L
Biomed Pharmacother; 2022 Sep; 153():113512. PubMed ID: 36076599
[TBL] [Abstract][Full Text] [Related]
2. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
[TBL] [Abstract][Full Text] [Related]
3. Neoplastic Transformation of the Peribiliary Stem Cell Niche in Cholangiocarcinoma Arisen in Primary Sclerosing Cholangitis.
Carpino G; Cardinale V; Folseraas T; Overi D; Grzyb K; Costantini D; Berloco PB; Di Matteo S; Karlsen TH; Alvaro D; Gaudio E
Hepatology; 2019 Feb; 69(2):622-638. PubMed ID: 30102768
[TBL] [Abstract][Full Text] [Related]
4. Peribiliary Gland Niche Participates in Biliary Tree Regeneration in Mouse and in Human Primary Sclerosing Cholangitis.
Carpino G; Nevi L; Overi D; Cardinale V; Lu WY; Di Matteo S; Safarikia S; Berloco PB; Venere R; Onori P; Franchitto A; Forbes SJ; Alvaro D; Gaudio E
Hepatology; 2020 Mar; 71(3):972-989. PubMed ID: 31330051
[TBL] [Abstract][Full Text] [Related]
5. Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis.
Carpino G; Cardinale V; Renzi A; Hov JR; Berloco PB; Rossi M; Karlsen TH; Alvaro D; Gaudio E
J Hepatol; 2015 Nov; 63(5):1220-8. PubMed ID: 26119688
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis.
De Muynck K; Heyerick L; De Ponti FF; Vanderborght B; Meese T; Van Campenhout S; Baudonck L; Gijbels E; Rodrigues PM; Banales JM; Vesterhuus M; Folseraas T; Scott CL; Vinken M; Van der Linden M; Hoorens A; Van Dorpe J; Lefere S; Geerts A; Van Nieuwerburgh F; Verhelst X; Van Vlierberghe H; Devisscher L
Hepatology; 2024 Feb; 79(2):269-288. PubMed ID: 37535809
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2
Zhou T; Kyritsi K; Wu N; Francis H; Yang Z; Chen L; O'Brien A; Kennedy L; Ceci L; Meadows V; Kusumanchi P; Wu C; Baiocchi L; Skill NJ; Saxena R; Sybenga A; Xie L; Liangpunsakul S; Meng F; Alpini G; Glaser S
EBioMedicine; 2019 Oct; 48():130-142. PubMed ID: 31522982
[TBL] [Abstract][Full Text] [Related]
8. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
Chung BK; Karlsen TH; Folseraas T
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis.
Zen Y; Liberal R; Nakanuma Y; Heaton N; Portmann B
J Hepatol; 2013 Nov; 59(5):1059-64. PubMed ID: 23811304
[TBL] [Abstract][Full Text] [Related]
10. The Role of CCL24 in Primary Sclerosing Cholangitis: Bridging Patient Serum Proteomics to Preclinical Data.
Greenman R; Snir T; Katav A; Aricha R; Mishalian I; Hay O; Frankel M; Lawler J; Saffioti F; Pinzani M; Thorburn D; Peled A; Mor A; Vaknin I
Cells; 2024 Jan; 13(3):. PubMed ID: 38334601
[TBL] [Abstract][Full Text] [Related]
11. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
[TBL] [Abstract][Full Text] [Related]
12. Beta-lapachone ameliorates the progression of primary sclerosing cholangitis pathogenesis in rodent models.
Woo SH; Lee SH; Moon SJ; Han J; Seo KS; Lee H; Lee CH; Hwang JH
Life Sci; 2024 Jan; 337():122342. PubMed ID: 38092141
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis.
Tsuneyama K; Kono N; Yamashiro M; Kouda W; Sabit A; Sasaki M; Nakanuma Y
J Pathol; 1999 Dec; 189(4):609-14. PubMed ID: 10629565
[TBL] [Abstract][Full Text] [Related]
14. Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
Pollheimer MJ; Racedo S; Mikels-Vigdal A; Marshall D; Bowlus C; Lackner C; Madl T; Karlsen TH; Hov JR; Lyman SK; Adamkewicz J; Smith V; Moreau E; Zollner G; Eide TJ; Stojakovic T; Scharnagl H; Gruber HJ; Stauber RE; Trauner M; Fickert P
J Hepatol; 2018 Aug; 69(2):368-377. PubMed ID: 29709678
[TBL] [Abstract][Full Text] [Related]
15. Animal models for primary sclerosing cholangitis.
Vierling JM
Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):591-610. PubMed ID: 11492970
[TBL] [Abstract][Full Text] [Related]
16. New insights into autoimmune cholangitis through animal models.
Trauner M; Fickert P; Baghdasaryan A; Claudel T; Halilbasic E; Moustafa T; Wagner M; Zollner G
Dig Dis; 2010; 28(1):99-104. PubMed ID: 20460897
[TBL] [Abstract][Full Text] [Related]
17. Senescent cholangiocytes release extracellular vesicles that alter target cell phenotype via the epidermal growth factor receptor.
Al Suraih MS; Trussoni CE; Splinter PL; LaRusso NF; O'Hara SP
Liver Int; 2020 Oct; 40(10):2455-2468. PubMed ID: 32558183
[TBL] [Abstract][Full Text] [Related]
18. Genetic or pharmacological reduction of cholangiocyte senescence improves inflammation and fibrosis in the
Alsuraih M; O'Hara SP; Woodrum JE; Pirius NE; LaRusso NF
JHEP Rep; 2021 Jun; 3(3):100250. PubMed ID: 33870156
[TBL] [Abstract][Full Text] [Related]
19. Recombinant adeno-associated virus 8-mediated inhibition of microRNA let-7a ameliorates sclerosing cholangitis in a clinically relevant mouse model.
Hua H; Zhao QQ; Kalagbor MN; Yu GZ; Liu M; Bian ZR; Zhang BB; Yu Q; Xu YH; Tang RX; Zheng KY; Yan C
World J Gastroenterol; 2024 Feb; 30(5):471-484. PubMed ID: 38414587
[TBL] [Abstract][Full Text] [Related]
20. Early Peribiliary Hyperenhancement on MRI in Patients with Primary Sclerosing Cholangitis: Significance and Association with the Mayo Risk Score.
Ni Mhuircheartaigh JM; Lee KS; Curry MP; Pedrosa I; Mortele KJ
Abdom Radiol (NY); 2017 Jan; 42(1):152-158. PubMed ID: 27472938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
